Page 58 - MI-1-2
P. 58

Microbes & Immunity                                                   A disruptive solution for endometriosis



               endometriosis. Fertil Steril. 2023;120(3):682-694.  coupled  receptor,  VPAC1,  mediates  vasoactive  intestinal
                                                                  peptide-dependent functional homeostasis of the gut
               doi: 10.1016/j.fertnstert.2023.03.032
                                                                  microbiota. Gastro Hep Adv. 2022;1(2):253-264.
            29.  Tang F, Deng M, Xu C,  et al. Unraveling the microbial
               puzzle: Exploring the intricate role of gut microbiota in      doi: 10.1016/j.gastha.2021.11.005
               endometriosis pathogenesis.  Front Cell Infect Microbiol.   40.  Meroni M, Longo M, Dongiovanni P. Alcohol or gut
               2024;14:1328419.                                   microbiota: Who is the guilty? Int J Mol Sci. 2019;20(18):4568.
               doi: 10.3389/fcimb.2024.1328419                    doi: 10.3390/ijms20184568
            30.  Salmeri N, Sinagra E, Dolci C, et al. Microbiota in irritable   41.  Harada T, Iwabe T, Terakawa N. Role of cytokines in
               bowel syndrome and endometriosis: Birds of a feather flock   endometriosis. Fertil Steril. 2001;76(1):1-10.
               together-A review. Microorganisms. 2023;11(8):2089.
                                                                  doi: 10.1016/s0015-0282(01)01816-7
               doi: 10.3390/microorganisms11082089
                                                               42.  Nothnick WB. Treating endometriosis as an autoimmune
            31.  Chiaffarino F, Cipriani S, Ricci E,  et al. Endometriosis   disease. Fertil Steril. 2001;76(2):223-231.
               and inflammatory bowel disease: A  systematic review
               of the literature.  Eur J Obstet Gynecol Reprod Biol.      doi: 10.1016/s0015-0282(01)01878-7
               2020;252:246-251.                               43.  Fahrenkrug  J.  Vasoactive  intestinal  polypeptide:
               doi: 10.1016/j.ejogrb.2020.06.051                  Measurement, distribution and putative neurotransmitter
                                                                  function. Digestion. 1979;19(3):149-169.
            32.  Dang Y, Zhang S. Causal relationship between endometriosis
               and  inflammatory  bowel  disease:  A   Mendelian     doi: 10.1159/000198339
               randomization analyses. Clin Transl Med. 2024;14(1):e1496.  44.  Martínez C, Juarranz Y, Gutiérrez-Cañas I, et al. A Clinical
               doi: 10.1002/ctm2.1496                             approach for the use of VIP axis in inflammatory and
                                                                  autoimmune diseases. Int J Mol Sci. 2019;21(1):65.
            33.  Dang C, Chen Z, Chai Y, et al. Assessing the relationship
               between gut microbiota and endometriosis: A bidirectional      doi: 10.3390/ijms21010065
               two-sample Mendelian randomization analysis.  BMC   45.  Ribatti D,  Conconi  MT,  Nussdorfer  GG.  Nonclassic
               Womens Health. 2024;24(1):123.                     endogenous novel regulators of angiogenesis.  Pharmacol
               doi: 10.1186/s12905-024-02945-z                    Rev. 2007;59(2):185-205.
            34.  Cao T, Wang Y, Huimin S. Causal effects between gut      doi: 10.1124/pr.59.2.3
               microbiota and endometriosis: A  two-sample Mendelian   46.  Pilzer I, Gozes I. VIP provides cellular protection through
               randomisation study. J Obstet Gynaecol. 2024;44(1):2362415.  a specific splice variant of the PACAP receptor: A  new
               doi: 10.1080/01443615.2024.2362415                 neuroprotection target. Peptides. 2006;27(11):2867-2876.
            35.  Haneishi Y, Furuya Y, Hasegawa M, Picarelli A, Rossi M,      doi: 10.1016/j.peptides.2006.06.007
               Miyamoto J. Inflammatory bowel diseases and gut   47.  Bourlev V, Moberg C, Ilyasova N, Davey E, Kunovac Kallak T,
               microbiota. Int J Mol Sci. 2023;24(4):3817.        Olovsson M. Vasoactive intestinal peptide is upregulated in
               doi: 10.3390/ijms24043817                          women with endometriosis and chronic pelvic pain. Am J
                                                                  Rep Immunol. 2018;80(3):e12857.
            36.  Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing
               study  in twins shows  that  gastrointestinal microbial      doi: 10.1111/aji.12857
               profiles vary with inflammatory bowel disease phenotypes.   48.  Astruc A, Roux L, Robin F,  et al. Advanced insights into
               Gastroenterology. 2010;139(6):1844-1854.e1.        human uterine innervation: Implications for endometriosis
               doi: 10.1053/j.gastro.2010.08.049                  and pelvic pain. J Clin Med. 2024;13(5):1433.
            37.  Kim JS, Kirkland RA, Lee SH,  et al. Gut microbiota      doi: 10.3390/jcm13051433
               composition modulates inflammation and structure of the   49.  Berard AR, Brubaker DK, Birse K, et al. Vaginal epithelial
               vagal afferent pathway. Physiol Behav. 2020;225:113082.  dysfunction is mediated by the microbiome, metabolome,
               doi: 10.1016/j.physbeh.2020.113082                 and mTOR signaling. Cell Rep. 2023;42(5):112474.
            38.  Gonzales  J,  Gulbransen  BD.  The  microbiota  conducts  the      doi: 10.1016/j.celrep.2023.112474
               vasoactive intestinal polypeptide orchestra in the small   50.  Seillet C, Luong K, Tellier J,  et al. The neuropeptide VIP
               intestine. Cell Mol Gastroenterol Hepatol. 2024;17(3):503-504.  confers anticipatory mucosal immunity by regulating ILC3
               doi: 10.1016/j.jcmgh.2023.11.013                   activity. Nat Immunol. 2020;21(2):168-177.
            39.  Ericsson AC, Bains M, McAdams Z, et al. The G protein-     doi: 10.1038/s41590-019-0567-y


            Volume 1 Issue 2 (2024)                         52                               doi: 10.36922/mi.4389
   53   54   55   56   57   58   59   60   61   62   63